North America Blood Glucose Monitoring Market Industry: Market Size & Forecast 2026

The North America blood glucose monitoring market encompasses self-monitoring devices, continuous glucose monitoring (CGM) systems, and complementary consumables such as test strips and lancets. The market is concentrated primarily in the United States, which accounts for the largest share, followed by Canada, where rising healthcare expenditure and diabetes diagnosis rates are expanding demand. Valued at approximately $7.67 billion in 2025, the market is experiencing steady expansion across both personal and clinical use settings.

• •Self-monitoring blood glucose devices and CGM systems represent the two primary product categories
• •The United States dominates regional market share due to high diabetes prevalence and advanced healthcare infrastructure
• •Consumables including test strips, lancets, and control solutions account for a recurring revenue segment

Rising prevalence of diabetes across all age groups, along with growing obesity rates, is a primary catalyst for market expansion. Advancements in non-invasive and minimally invasive monitoring technologies are improving patient compliance and clinical outcomes. Favorable reimbursement frameworks in the United States, combined with increasing healthcare awareness in Canada, are lowering adoption barriers and fueling demand.

• •Increasing incidence of Type 1 and Type 2 diabetes across North American populations
• •Growing preference for continuous and real-time glucose monitoring over traditional fingerstick methods
• •Expanding insurance coverage and Medicare reimbursement for CGM devices in the United States

The market is broadly segmented into self-monitoring blood glucose (SMBG) devices and continuous glucose monitoring (CGM) systems, with CGM technology capturing a growing share due to its accuracy and convenience. Geographically, the United States dominates with the highest per-capita adoption and the largest installed base of devices, while Canada represents a smaller but expanding market driven by an aging demographic. Product categories further divide into traditional glucose meters, test strips, lancets, and advanced sensor-based monitoring solutions.

• •CGM systems are growing faster than traditional SMBG devices, driven by technological improvements and patient preference
• •The United States accounts for the vast majority of regional market value, with Canada representing incremental growth
• •Geriatric populations and managed care programs are key demand segments influencing adoption patterns

What are the recent trends and outlook?

Integration of glucose monitoring with smartphone applications and digital health platforms is accelerating, enabling real-time data sharing between patients and healthcare providers. Miniaturization, longer-lasting sensors, and artificial intelligence-driven analytics are expected to drive the next phase of product evolution. The market is forecasted to maintain a robust growth trajectory through the early 2030s, supported by ongoing clinical evidence, expanding insurance coverage, and increasing emphasis on preventive diabetes management.

• •Smartphone-connected glucose monitors with cloud-based data analytics are gaining adoption
• •Non-invasive glucose monitoring technologies under development could reshape market dynamics
• •Expansion of telehealth and remote patient monitoring is creating new demand channels for connected glucose devices